Going into the third year of the global pandemic, residents of China's largest city are feeling uncertainty around potential extended lockdowns for the first time, the impact of which could affect a major research and headquarters hub for the pharma industry in the country.
Shanghai is reporting record numbers of COVID-19 infections, official data pointing to 977 asymptomatic cases and four confirmed infections as...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

